Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionTwin Tree Management, LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Twin Tree Management, LP ownership in NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Twin Tree Management, LP filed a 13F-HR form disclosing ownership of 0 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 6,341 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -100.00% during the quarter.

Twin Tree Management, LP has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 17,300 of underlying shares valued at $2,279,102 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -6,341 -100.00 0 -100.00
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,341 1,531 31.83 899 33.19 0.0078
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,810 4,810 675 0.0028
2025-02-10 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -28,105 -100.00 0 -100.00
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,105 28,105 3,238 0.0063
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -19,147 -100.00 0 -100.00
2024-05-09 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,147 -17,764 -48.13 2,641 -45.71 0.0058
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 36,911 12,712 52.53 4,863 78.66 0.0093
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,199 19,022 367.43 2,722 457.79 0.0061
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,177 5,177 488 0.0007
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -12,477 -100.00 0 -100.00
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,477 7,812 167.46 1,325 191.21 0.0025
2022-08-11 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,665 -7,182 -60.62 455 -59.05 0.0007
2022-05-11 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,847 9,053 324.02 1,111 366.81 0.0018
2022-02-10 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,794 -11,800 -80.86 238 -83.00 0.0005
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,594 -8,883 -37.84 1,400 -38.73 0.0031
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,477 17,310 280.69 2,285 280.83 0.0061
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,167 4,397 248.42 600 252.94 0.0022
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,770 -5,880 -76.86 170 -76.90 0.0007
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,650 2,479 47.94 736 16.64 0.0030
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,171 5,121 10,242.00 631 15,675.00 0.0026
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 50 -2,589 -98.11 4 -98.59 0.0000
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,639 122 4.85 284 25.11 0.0010
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,517 2,517 227 0.0009
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -2,118 -100.00 0 -100.00
2019-05-10 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,118 -1,219 -36.53 187 -21.43 0.0010
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,337 3,337 238 0.0015
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Call 17,300 17,200.00 2,279 16,178.57 n/a n/a n/a
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 100 -98.73 14 -98.74 n/a n/a n/a
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Call 7,900 -88.92 1,109 -87.62 n/a n/a n/a
2025-07-28 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 71,300 249.51 8,962 297.21 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Call 20,400 -13.92 2,256 -30.26 n/a n/a n/a
2025-02-10 2024-12-31 13F NEUROCRINE BIOSCIENCES ORDINARY SHARES Call 23,700 12.32 3,235 33.07 n/a n/a n/a
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 21,100 2,431 n/a n/a n/a
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 1,100 107 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 13,400 -10.67 1,207 -4.66 n/a n/a n/a
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 15,000 837.50 1,266 797.87 n/a n/a n/a
2019-05-10 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 1,600 141 n/a n/a n/a
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-09 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Call 8,900 0.00 1,094 25.17 n/a n/a n/a
2018-08-07 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Call 8,900 874 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 18,700 0.00 2,652 1.03 n/a n/a n/a
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Put 18,700 -1.58 2,625 9.92 n/a n/a n/a
2025-07-28 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Put 19,000 156.76 2,388 191.93 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 7,400 -93.02 818 -94.35 n/a n/a n/a
2025-02-10 2024-12-31 13F NEUROCRINE BIOSCIENCES ORDINARY SHARES Put 106,000 -14.72 14,469 1.03 n/a n/a n/a
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 124,300 781.56 14,322 637.82 n/a n/a n/a
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 14,100 1,941 n/a n/a n/a
2024-05-09 2024-03-31 13F NEUROCRINE BIOSCIENCES PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES PUT Put 24,900 3,281 n/a n/a n/a
2021-08-12 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 35,500 3,452 n/a n/a n/a
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Put 16,300 0.00 1,752 19.26 n/a n/a n/a
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Put 16,300 226.00 1,469 248.10 n/a n/a n/a
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 5,000 0.00 422 -4.09 n/a n/a n/a
2019-05-10 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 5,000 -45.65 440 -33.03 n/a n/a n/a
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Put 9,200 657 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.